← All organizations

Boston Therapeutics

For profitWebsite ↗

Also known as: Boston Therapeutics | Sugardown Company Limited

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Sep 24, 2018

Timeline

2000s

Jun 1, 2009
Boston Therapeutics— Founded

2010s

Feb 13, 2018
CureDM— Acquired

Drugs by trial phase (6 distinct, 9 trials)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (0 own, 1 via acquisition)

human proislet peptide

Other trials (3 own, 0 via acquisition)

Indications

Studied for

Subsidiaries (1 direct, 1 total across the full acquisition tree)

CureDM

Recent trials (8)

NCT03655535Lead sponsorPhase 1/Phase 2Sep 24, 2018
NCT03655535CollaboratorPhase 1/Phase 2Sep 24, 2018
NCT02358668CollaboratorPhase 2Mar 30, 2015
NCT03374501Lead sponsorN/ANov 30, 2014
NCT02135549Lead sponsorN/AMay 1, 2014
NCT04569214Lead sponsorPhase 2Sep 30, 2012
NCT03375398Lead sponsorN/AMar 31, 2011
NCT02060916Lead sponsorPhase 2Mar 1, 2011

Details

Founded: Lawrence, MA, US Jun 1, 2009
Last known activity: Sep 24, 2018